Search dm+d | This AMP cannot be matched against our prescribing data.
| Description | Nucala 100mg/1ml solution for injection pre-filled pens (GlaxoSmithKline UK Ltd) |
| BNF code | 0304020Y0BBACAC |
| Virtual Medicinal Product | Mepolizumab 100mg/1ml solution for injection pre-filled disposable devices |
| Name | Nucala 100mg/1ml solution for injection pre-filled pens |
| Date of name applicability | 27 Feb 2020 |
| Previous name | Nucala 100mg/1ml solution for injection pre-filled pen |
| Supplier | GlaxoSmithKline UK Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Subcutaneous |
| Actual Medicinal Product Packs | |
| Nucala 100mg/1ml solution for injection pre-filled pens (GlaxoSmithKline UK Ltd) 1 pre-filled disposable injection | |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.